In vivo lineage tracing revealed that anti-CD276 effectively eliminated CSCs in a CD8+ T-cell-dependent manner.138 In the future, it will be interesting to examine how immune check blockade modifies the landscape of HNSCC heterogeneity. The gene discussed is CD276; the disease is head and neck squamous cell carcinoma.